Airway Management Devices Market: Current Analysis and Forecast (2021-2027)

Airway Management Devices Market: Current Analysis and Forecast (2021-2027)

  • UnivDatos Market Insight
  • August 2021
  • Healthcare
  • 163 pages

Report Description

Airway management comprises set of medical procedures to prevent airway obstruction in patients. This device safeguards an open pathway in patients that allows the gas exchange between a patient's lungs and the atmosphere. There are various products such as oropharyngeal airway, nasopharyngeal airways, laryngeal mask airways and tracheal incubation used in providing airway in patients who are undergoing anesthesia procedures in hospitals. These devices are found to be used in fields of anesthesia, cardiopulmonary resuscitation, emergency medicine, neonatology, and many others. In neonatology it has application for managing airway among babies and increasing incidence of preterm birth may require the need of airway management. For instance, according to World Health Organization, stated in 2018, approximately 15 million preterm babies are born each year (before 37 weeks of gestation), which is more than 1 out of 10 infants and this number is increasing per year. In 184 nations, preterm birth rates vary from 5% to 18% of infants born. Increase in preterm birth worldwide is one of the major factors in driving the market.

Based on type the global Airway Management Devices Market is segmented into Infraglottic Airway Management Devices, Supraglottic Airway Management Devices, Laryngoscopes, Resuscitators, and Others. Currently, Infraglottic devices segment is expected to dominate the market by holding largest market share during the forecast period. Surging demand for positive air pressure ventilation among the patients facing respiratory failure is driving the demand for intubation, thereby contributing to the growth of this segment. The Infraglottic devices such as endotracheal tubes and tracheostomy tubes are used during intubation for rescuing airway and provide ventilation after connecting with external breathing assistance systems.

In terms of application, the market is grouped into Anesthesia, Emergency Medicine and Others. Among them, the anesthesia segment is forecasted to lead the market share during the forecast period. This can be ascribed to the increasing growth in the number of surgical interventions globally, that require the patients to be provided with anesthesia. 

By patient age, the global Airway Management Devices Market is segmented into Adult Patients and Pediatric/Neonatal Patients. Adult segment is dominating the market. The growing adult population and the increase in the occurrence of chronic diseases in geriatric patients are the key factors contributing for the of adult patients age segment. According to the Centers for Disease Control and Prevention (CDC), in 2015, total number of the emergency department visit with the chronic diseases in the U.S. are Chronic obstructive pulmonary disease (COPD) 7,251, Congestive heart failure 4,413 Hypertension 32,370 per thousand patients.

Based on end-user the market is categorized into Hospitals, Ambulatory Care Settings, Home Care Settings and Others. At present, hospital segment dominates the market and is expected to maintain its dominance during the analyzed period as well. This supremacy is ascribed to growing rising number of hospitals and infrastructural & economic development, especially in emerging countries. In addition to this, increase in surgical procedures performed-where airway management devices are used for ventilation, oxygenation, and the administration of anesthesia-also supports high growth in the hospitals segment.

For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of APAC), and Rest of World. North America has dominated the Airway Management Devices market which is attributable to the presence of a highly developed healthcare system, the increasing number of healthcare settings, the rising prevalence of chronic respiratory diseases, significant number of prominent vendors, and favorable reimbursement policies for airway management devices.

Moreover, Asia Pacific region is anticipated to witness highest growth over the next 5 years on account of presence of high-growth markets such as India, China, and Japan; rapid growth in the geriatric population; increasing demand for critical care units; the implementation of favorable government initiatives; growing per capita income; increasing investments in the healthcare industry; the rising demand for cutting-edge technologies; and the expansion of private-sector hospitals to rural areas. 

In addition, the Asia Pacific is becoming a medical tourism hub and is considered one of the fastest-growing markets for medical procedures and devices. Low infrastructure and treatment costs and the availability of highly educated physicians have driven medical tourists to APAC countries, particularly to India, Malaysia, and China. Furthermore, high R&D investment by the global players and the presence of unexplored opportunities in this region serve as high growth rendering drivers.

Some of the major players operating in the market include Medtronic Plc, Smiths Medical (Smiths Group Plc), Teleflex Inc, Ambu A/S, Convatec Group, Karl Storz Se & Co. Kg, Flexicare, Intersurgical, Sunmed and Vyaire Medical Inc.

Global Airway Management Devices Market was valued at US$ XX billion in 2020 and is anticipated to reach US$ XX billion by 2027 displaying an elevated CAGR of XX% over the forecast period (2021-2027). The demand for Airway Management Devices Market is increasing on account of increasing prevalence of respiratory diseases such as Asthma and COPD cases, rise in the aging population, increase in urbanization and pollution, growing investments in healthcare infrastructure, favourable reimbursement coverage across developed countries, increase in the preterm birth cases, and lifestyle changes. According to the WHO estimates, 65 million people suffer from moderate-to-severe COPD. Moreover, COPD is predicted to be the third leading cause of death worldwide.  In addition to the abovementioned factors, increasing need for emergency treatment for prolonged illnesses as well as protracted treatments associated with lung diseases in children and adults is serving as a huge opportunity.  

Patients suffering from infectious, chronic, and cardiac conditions often experience airway complications, which require immediate treatment. According to the 2019 health data of CDC, the number of emergency department visits among adults aged 18 years and above in the US has increased by about 8.67% during 1997-2018.

Airway management comprises set of medical procedures to prevent airway obstruction in patients. This device safeguards an open pathway in patients that allows the gas exchange between a patient's lungs and the atmosphere. There are various products such as oropharyngeal airway, nasopharyngeal airways, laryngeal mask airways and tracheal incubation which are used in providing airway in patients undergoing anesthesia procedures in hospitals. These devices are widely used in fields of anesthesia, cardiopulmonary resuscitation, emergency medicine, neonatology, and many others. In neonatology it has application for managing airway among babies and increasing incidence of preterm birth may require the need of airway management. For instance, according to World Health Organization, stated in 2018, approximately 15 million preterm babies are born each year (before 37 weeks of gestation), which is more than 1 out of 10 infants and this number is increasing per year. In 184 nations, preterm birth rates vary from 5% to 18% of infants born. Increase in preterm birth worldwide is one of the major factors in driving the market.

Though asthma prevalence cases are higher in children, mortality, and morbidity, cases are higher in adults. Moreover, the childhood asthma cases are more in boys whereas the adult asthma cases are more in women. As per the data shared by national and state surveillance systems administered by the Centers for Disease Control and Prevention (CDC), the young teens of 12-14 years old mostly suffers from a high prevalence of Asthma attacks. 

Medtronic Plc, Smiths Medical (Smiths Group Plc), Teleflex Inc, Ambu A/S, Convatec Group, Karl Storz Se & Co. Kg, Flexicare, Intersurgical, Sunmed and Vyaire Medical Inc. are some of the prominent players operating in the global Airway Management Devices market. Several M&A’s along with partnerships have been undertaken by these players to develop new and advanced airway management devices products.

Insights Presented in the Report

“Amongst type, Infraglottic Airway Management Devices segment holds the major share”

Based on type the global Airway Management Devices Market is segmented into Infraglottic Airway Management Devices, Supraglottic Airway Management Devices, Laryngoscopes, Resuscitators, and Others. Currently, Infraglottic devices segment is expected to dominate the market by holding largest market share during the forecast period. Surging demand for positive air pressure ventilation among the patients facing respiratory failure is driving the demand for intubation, thereby contributing to the growth of this segment. The Infraglottic devices such as endotracheal tubes and tracheostomy tubes are used during intubation for rescuing airway and provide ventilation after connecting with external breathing assistance systems.

“Amongst patient age, Adult Patients segment holds the major share”

By patient age, the global Airway Management Devices Market is segmented into Adult Patients and Pediatric/Neonatal Patients. Adult segment is dominating the market. The growing adult population and the increase in the occurrence of chronic diseases in geriatric patients are the key factors contributing for the of adult patients age segment. According to the Centers for Disease Control and Prevention (CDC), in 2015, total number of the emergency department visit with the chronic diseases in the U.S. are Chronic obstructive pulmonary disease (COPD) 7,251, Congestive heart failure 4,413 Hypertension 32,370 per thousand patients.

“Amongst application, the Anesthesia segment holds the major share”

In terms of application, the market is grouped into Anesthesia, Emergency Medicine and Others. Among them, the anesthesia segment is forecasted to lead the market share during the forecast period. This can be ascribed to the increasing growth in the number of surgical interventions globally, that require the patients to be provided with anesthesia.

“Amongst end-user, the Hospitals segment holds the major share”

Based on end-user the market is categorized into Hospitals, Ambulatory Care Settings, Home Care Settings and Others. At present, hospital segment dominates the market and is expected to maintain its dominance during the analyzed period as well. This supremacy is ascribed to growing rising number of hospitals and infrastructural & economic development, especially in emerging countries. In addition to this, increase in surgical procedures performed-where airway management devices are used for ventilation, oxygenation, and the administration of anesthesia-also supports high growth in the hospitals segment. As per the Pan American Health Organization, 75% of all hospitalized patients require supplemental oxygen treatment. 

“North America signifies one of the largest markets of Airway Management Devices Market”

For a better understanding of the market dynamics of the Airway Management Devices market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX million in 2020 which is attributable to the presence of a highly developed healthcare system, the increasing number of healthcare settings, the rising prevalence of chronic respiratory diseases, the significant number of prominent vendors, and favorable reimbursement policies for airway management devices in the region. At the same time, Asia-Pacific is anticipated to grow at the highest CAGR of XX% during the forecast period.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The Airway Management Devices market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Companies Covered

  • Medtronic Plc
  • Smiths Medical (Smiths Group Plc)
  • Teleflex Inc
  •  Ambu A/S
  • Convatec Group
  • Karl Storz Se & Co. Kg
  • Flexicare
  • Intersurgical
  • Sunmed
  • Vyaire Medical Inc.

Have query on this report?

Make an Enquiry

Table of Content

1. MARKET INTRODUCTION
1.1. Market Definitions
1.2. Objective of the Study
1.3. Limitation
1.4. Stake Holders
1.5. Currency Used in Report
1.6. Scope of the Digital Therapeutics Market Study

2. RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Methodology for the Global Airway Management Devices Market
2.1.1.Main Objective of the Global Airway Management Devices Market

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. AIRWAY MANAGEMENT DEVICES AMID COVID-19

6. GLOBAL AIRWAY MANAGEMENT DEVICES MARKET REVENUE (USD BN), 2019-2027F

7. MARKET INSIGHTS BY TYPE

7.1. Infraglottic Airway Devices
7.1.1.Endotracheal tubes
7.1.2.Tracheostomy tubes
7.2. Supraglottic Airway Devices
7.2.1.Laryngeal Mask Airways
7.2.2.Oropharyngeal Airways
7.2.3.Nasopharyngeal Airways
7.2.4.Others
7.3. Laryngoscopes
7.3.1.Conventional Laryngoscope
7.3.2.Video Laryngoscope 
7.4. Resuscitators
7.5. Others

8. MARKET INSIGHTS BY PATIENT AGE
8.1. Adult Patients
8.2. Paediatric Patients/Neonates

9. MARKET INSIGHTS BY APPLICATION
9.1. Anaesthesia
9.2. Emergency Medicine
9.3. Others
10. MARKET INSIGHTS BY END-USER
10.1. Hospitals
10.2. Ambulatory Care Settings
10.3. Home Care Settings
10.4. Others

11. MARKET INSIGHTS BY REGION 
11.1. North America Airway Management Devices Market 
11.1.1. United States
11.1.2. Canada
11.1.3. Rest of North America
11.2.  Europe Airway Management Devices Market 
11.2.1. Germany
11.2.2. France
11.2.3. United Kingdom
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia Pacific Airway Management Devices Market
11.3.1. China
11.3.2. Japan
11.3.3. India
11.3.4. South Korea
11.3.5. Rest of Asia Pacific
11.4. Rest of World Airway Management Devices Market 

12. AIRWAY MANAGEMENT DEVICES MARKET DYNAMICS
12.1. Market Drivers
12.2. Market Challenges
12.3. Impact Analysis

13. AIRWAY MANAGEMENT DEVICES MARKET OPPORTUNITIES

14. AIRWAY MANAGEMENT DEVICES MARKET TRENDS

15. LEGAL & REGULATORY FRAMEWORK

16. DEMAND AND SUPPLY SIDE ANALYSIS

16.1. Demand Side Analysis
16.2. Supply Side Analysis
16.2.1. Top Product Launches
16.2.2. Top Business Partnerships
16.2.3. Top Business Expansions, Investments and Divestitures
16.2.4. Top Merger and Acquisitions

17. VALUE CHAIN ANALYSIS

18. COMPETITIVE SCENARIO

18.1. Porter’s Five Forces Analysis
18.1.1. Bargaining power of Supplier
18.1.2. Bargaining power of Buyer
18.1.3. Industry Rivalry
18.1.4. Availability of Substitute
18.1.5. Threat of new Entrants
18.2. Competitive Landscape
18.2.1.  Company Shares, By Revenue

19. COMPANY PROFILED
19.1. Medtronic Plc.
19.2. Smiths Medical (Smiths Group Plc)
19.3. Teleflex Inc
19.4. Ambu A/S
19.5. Convatec Group
19.6. Karl Storz Se & Co. Kg
19.7. Flexicare
19.8. Intersurgical
19.9. Sunmed
19.10. Vyaire Medical Inc.

20. DISCLAIMER

Success Stories

Our Clients